Prelude Therapeutics Inc

NASDAQ:PRLD   3:59:50 PM EDT
14.80
+0.96 (+6.94%)
Earnings Announcements

Prelude Therapeutics Q3 Loss Per Share $0.66

Published: 11/12/2021 14:29 GMT
Prelude Therapeutics Inc (PRLD) - Q3 Loss per Share $0.66.
Prelude Therapeutics - Believes Current Cash, Cash Equivalents & Marketable Securities Will Be Sufficient to Fund Operating Expenses Into 2nd Half of 2023.
Q3 Earnings per Share View $-0.63 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.68

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.76

More details on our Analysts Page.